Skip to main content
. 2016 Mar 21;34(14):1634–1643. doi: 10.1200/JCO.2015.66.3567

Table 2.

Excess Risk of All-Cause and Cause-Specific Mortality Across Racial/Ethnic Groups of Childhood Cancer Survivors: Relative Rate

All-Cause Subsequent Neoplasm* Subsequent Malignancy Cardiac Cause
RR of Mortality RR (95% CI) P RR (95% CI) P RR (95% CI) P RR (95% CI) P
Adjusted for clinical/demographic variables
 NHW Ref Ref Ref Ref
 NHB 1.5 (1.1 to 2.0) .004 1.5 (0.9 to 2.4) .15 1.2 (0.7 to 2.1) .53 2.1 (0.7 to 6.3) .19
 Hispanic 1.1 (0.9 to 1.5) .35 1.0 (0.5 to 1.7) .92 0.9 (0.5 to 1.7) .77 2.0 (0.9 to 4.5) .09
Adjusted for clinical/demographic variables and treatment
 NHW Ref Ref Ref Ref
 NHB 1.4 (1.1 to 1.9) .008 1.4 (0.9 to 2.4) .18 1.2 (0.7 to 2.1) .58 2.0 (0.7 to 6.2) .21
 Hispanic 1.1 (0.8 to 1.4) .53 0.9 (0.5 to 1.7) .82 0.9 (0.5 to 1.7) .68 1.8 (0.8 to 4.2) .15
Adjusted for clinical/demographic variables, treatment, and SES§
 NHW Ref Ref Ref Ref
 NHB 1.0 (0.8 to 1.4) .88 1.1 (0.6 to 2.0) .71 0.9 (0.5 to 1.8) .80 1.6 (0.6 to 4.8) .37
 Hispanic 0.9 (0.7 to 1.2) .46 0.8 (0.4 to 1.4) .37 0.7 (0.4 to 1.4) .38 1.5 (0.7 to 3.5) .34
Adjusted for clinical/demographic variables, treatment, SES, and CVRF||
 NHW Ref Ref Ref Ref
 NHB 1.0 (0.8 to 1.4) .89 1.1 (0.6 to 2.0) .65 0.9 (0.5 to 1.8) .87 1.2 (0.4 to 3.4) .70
 Hispanic 0.9 (0.7 to 1.1) .31 0.8 (0.4 to 1.4) .37 0.7 (0.4 to 1.5) .39 1.6 (0.7 to 3.8) .28

Abbreviations: CVRF, cardiovascular risk factors; NHB, non-Hispanic black; NHW, non-Hispanic white; Ref, reference; RR, relative rate; SES, socioeconomic status.

*

Subsequent neoplasm included both malignancies and benign subsequent neoplasms.

Clinical/demographic variables include sex, age at diagnosis, diagnosis, treatment era, and attained age as natural cubic splines.

Treatment includes radiation therapy, alkylating agent cyclophosphamide equivalent dose, and anthracycline score.

§

SES includes education, annual household income, and health insurance as time-dependent variables.

||CVRF include obesity, diabetes, hypertension, and dyslipidemia.